Search
West Pharmaceutical Services Inc
WSTAdd to Watchlist
392.150USD
-1.880-0.48%
Close 10-23 16:00（ET）
27.60BMarket Cap
52.16P/E TTM
After-hours 19:00 (ET)392.150USD+0.155+0.04%
After-hours 19:00 (ET)West Pharmaceutical Services Inc (WST) Stock Price Target & Forecast
Analyst Rating
Based on 18 analysts giving stock ratings to West Pharmaceutical Services Inc in the past month.
Buy
6 Strong Buy
12 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
407.674USD+6.16%
WST Analyst Recommendation Trends
In the current month, WST has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. WST average Analyst price target in the last month is 407.674.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
6
6
6
7
6
5
5
5
12
12
12
10
9
11
10
10
0
0
1
1
3
3
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
18
19
18
18
19
19
19
WST Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
11
11
0
0
31
Dexcom Inc
DXCM
13
13
4
0
0
30
Abbott Laboratories
ABT
11
14
4
0
0
29
Stryker Corp
SYK
10
14
5
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
13
3
0
0
21
Financial Forecasting
Based on analysts' estimates, WST EPS is projected to reach 2.193 in FY2026Q3, following reported EPS of 2.175 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.83
1.68
2.08
2.19
2.27
Actual
1.83
1.93
2.18
--
--
Surprise
-0.28%
+14.97%
+4.53%
--
--
FAQs
What is West Pharmaceutical Services Inc's expected revenue for the next quarter?
West Pharmaceutical Services Inc's expected revenue is 825.70M.
What is West Pharmaceutical Services Inc's price target?
Analysts forecast that West Pharmaceutical Services Inc's price target is USD 407.67, with the highest forecast at USD 459.00 and the lowest forecast at USD 337.00.
How have West Pharmaceutical Services IncWST's recent earnings per share performed?
The market expectation was USD 2.18, while West Pharmaceutical Services IncWST's earnings per share (EPS) for the previous quarter was USD 1.93. EPS for the next quarter is expected at USD 2.19.
What is the analyst rating for West Pharmaceutical Services Inc?
Based on the ratings of West Pharmaceutical Services Inc's stock from 18 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.